收费全文 | 24848篇 |
免费 | 2018篇 |
国内免费 | 56篇 |
耳鼻咽喉 | 203篇 |
儿科学 | 931篇 |
妇产科学 | 723篇 |
基础医学 | 3213篇 |
口腔科学 | 259篇 |
临床医学 | 4308篇 |
内科学 | 4362篇 |
皮肤病学 | 328篇 |
神经病学 | 2320篇 |
特种医学 | 381篇 |
外科学 | 2131篇 |
综合类 | 452篇 |
一般理论 | 53篇 |
预防医学 | 3678篇 |
眼科学 | 247篇 |
药学 | 1454篇 |
中国医学 | 22篇 |
肿瘤学 | 1857篇 |
2023年 | 119篇 |
2022年 | 200篇 |
2021年 | 483篇 |
2020年 | 310篇 |
2019年 | 497篇 |
2018年 | 529篇 |
2017年 | 388篇 |
2016年 | 425篇 |
2015年 | 477篇 |
2014年 | 653篇 |
2013年 | 1134篇 |
2012年 | 1614篇 |
2011年 | 1629篇 |
2010年 | 905篇 |
2009年 | 841篇 |
2008年 | 1607篇 |
2007年 | 1773篇 |
2006年 | 1633篇 |
2005年 | 1603篇 |
2004年 | 1612篇 |
2003年 | 1448篇 |
2002年 | 1435篇 |
2001年 | 238篇 |
2000年 | 192篇 |
1999年 | 262篇 |
1998年 | 364篇 |
1997年 | 280篇 |
1996年 | 257篇 |
1995年 | 225篇 |
1994年 | 209篇 |
1993年 | 201篇 |
1992年 | 163篇 |
1991年 | 135篇 |
1990年 | 165篇 |
1989年 | 129篇 |
1988年 | 148篇 |
1987年 | 110篇 |
1986年 | 139篇 |
1985年 | 141篇 |
1984年 | 158篇 |
1983年 | 131篇 |
1982年 | 200篇 |
1981年 | 155篇 |
1980年 | 157篇 |
1979年 | 97篇 |
1978年 | 96篇 |
1977年 | 83篇 |
1976年 | 99篇 |
1974年 | 90篇 |
1973年 | 106篇 |
Areas covered: This review summarizes the evolution of renal mass biopsy to its current state with respect to outcomes, indications, and clinical guidelines.
Expert opinion: With improved understanding of differential biological potential of renal cortical neoplasms combined with technical improvements in diagnostic yield and accuracy, utilization of renal mass biopsy is becoming an important adjunct to patient care in a broad range of clinical scenarios, including active surveillance, thermal ablation, and use of primary systemic therapy in localized and advanced settings. 相似文献
Background
Current blunt cerebrovascular injury (BCVI) grading grossly differentiates injury characteristics such as luminal stenosis (LS) and aneurysmal disease. The effect of increasing degree of LS beyond the current BCVI grading scale on stroke formation is unknown.Study Design
BCVI over a 3-year period were retrospectively reviewed. To investigate influence of LS beyond the BCVI grading scale within aneurysmal and non-aneurysmal BCVI, grade 2 BCVI were subdivided into BCVI with ≥ 25% and ≤ 50% LS and BCVI with > 50% and ≤ 99% LS. Grade 3 BCVI were subdivided into BCVI with pseudoaneurysm (PSA) without LS and BCVI with PSA and LS. We hypothesized increased LS beyond the current BCVI grade distinctions would be associated with higher rates of stroke formation.Results
312 BCVI were included, of which 140 were carotid BCVI and 172 vertebral BCVI. Sixteen carotid BCVI underwent endovascular intervention (EI) and 19 suffered a stroke. In carotid BCVI stroke rates increased sequentially with BCVI grade except in grade 3. There was a stroke rate of 12% in grade 1 carotid BCVI, 18% in grade 2, 6% in grade 3, and 31% in grade 4. In subgroup analysis for grade 2 carotid BCVI, BCVI with > 50% and ≤ 99% LS had higher rates of stroke (22% vs. 15%, p?=?0.44) than BCVI with ≥ 25% and ≤ 50% LS. In subgroup analysis of grade 3 carotid BCVI, BCVI with PSA and LS had higher rates of stroke (9% vs. 4%, p?=?0.48) than BCVI with PSA without LS. Higher rates of EI in grade 2 carotid BCVI with > 50% and ≤ 99% LS (22% vs. 5%, p?=?0.14) and grade 3 carotid BCVI with PSA and LS (35% vs. 4%, p?=?0.01) were noted in subgroup analysis.Conclusion
Higher percentage LS beyond the currently used BCVI grading scale has a non-significantly increased rate of stroke in both aneurysmal and non-aneurysmal BCVI. Grade 3 BCVI with PSA and LS seems to be a high-risk subgroup. Use of EI confounds modern measurement of stroke risk in higher LS BCVI. 相似文献The metabolism of the pyrethroids deltamethrin (DLM), cis-permethrin (CPM) and trans-permethrin (TPM) was studied in human expressed cytochrome P450 (CYP) and carboxylesterase (CES) enzymes.
DLM, CPM and TPM were metabolised by human CYP2B6 and CYP2C19, with the highest apparent intrinsic clearance (CLint) values for pyrethroid metabolism being observed with CYP2C19. Other CYP enzymes contributing to the metabolism of one or more of the three pyrethroids were CYP1A2, CYP2C8, CYP2C9*1, CYP2D6*1, CYP3A4 and CYP3A5. None of the pyrethroids were metabolised by CYP2A6, CYP2E1, CYP3A7 or CYP4A11.
DLM, CPM and TPM were metabolised by both human CES1 and CES2 enzymes.
Apparent CLint values for pyrethroid metabolism by CYP and CES enzymes were scaled to per gram of adult human liver using abundance values for microsomal CYP enzymes and for CES enzymes in liver microsomes and cytosol. TPM had the highest and CPM the lowest apparent CLint values for total metabolism (CYP and CES enzymes) per gram of adult human liver.
Due to their higher abundance, all three pyrethroids were extensively metabolised by CES enzymes in adult human liver, with CYP enzymes only accounting for 2%, 10% and 1% of total metabolism for DLM, CPM and TPM, respectively.